 |
 |
 |
 |
 |
 |
 |
 |
 |
Conor Medsystems
Conor MedSystems (NASD:CONR) developed stents and other medical devices as platforms for controlled local and systemic delivery of a wide variety of therapeutic agents. The Company's initial focus was on drug-eluting stents for the treatment of restenosis and vascular disease. Conor went public in December 2004. Johnson & Johnson agreed to acquire Conor in November 2006.